Clinical Trials in San Francisco

Showing 6861-6880 of 12,991 trials

A Controlled Trial of Topiramate Treatment for Alcohol Dependence in Veterans With PTSD

NCT01749215

The goal of this project is to improve the treatment of veterans with co-occurring alcohol dependence and posttraumatic stress disorder (PTSD). The PI and co-investigators will conduct a controlled clinical trial of topiramate for the treatment of these co-occurring disorders.

Alcohol DependencePosttraumatic Stress Disorder (PTSD)

University of California, San Francisco151 participantsStarted Feb 2013

San Francisco, California, United States

TERMINATEDPhase 4< 1 mile

Delayed Start to Ovarian Stimulation

NCT01614067

In couples with infertility secondary to Diminished Ovarian Reserve, the investigators hypothesize that a delayed start (7 day) to ovarian stimulation with an GnRH antagonist (Ganirelix) will improve oocyte maturation and quality, and improve pregnancy outcomes.

Diminished Ovarian ReserveInfertilityIn Vitro Fertilization

University of California, San Francisco30 participantsStarted May 2012

San Francisco, California, United States

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of SPD503 in Combination With Psychostimulants

NCT00734578

The purpose of this study is to assess the efficacy and safety of SPD503 in subjects with ADHD when co-administered with psychostimulants in children and adolescents aged 6-17 years with a diagnosis of ADHD with a sub-optimal, partial response to stimulants.

ADHD

Shire461 participantsStarted Sep 2008

Dothan, Alabama, United States • Scottsdale, Arizona, United States • Little Rock, Arkansas, United States +58 more locations

A Controlled Trial of Topiramate Treatment for Alcohol Dependence in Veterans With PTSD

Delayed Start to Ovarian Stimulation

Efficacy and Safety of SPD503 in Combination With Psychostimulants

Find Trials by Condition in San Francisco

Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures

Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer

SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study

(C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis

Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer

A Study of Oral Hymecromone and Hyaluronan Synthesis

Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo

CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial

Impact of Curricular Transformation on Family Medicine Resident Burnout

Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder

Prevention of Recurrence of Diverticulitis

A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease

Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic Therapy

Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study

Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an Antidepressant

Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate